跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,788 条关于
“TG Therapeutics”
全部
16,788
临床试验
3,657
药物
3,183
机构
1,124
资讯
8,824
去年
TG Therapeutics' Briumvi Exceeds Expectations, Eyes Subcutaneous Formulation and Azer-Cel Trial in MS
6个月前
ACT Capital Management Invests $8 Million in TG Therapeutics Despite 30% Stock Decline
去年
TG Therapeutics Partners with MaxCyte to Advance Novel CAR T-Cell Therapy for Progressive MS
6个月前
TG Therapeutics Secures $500 Million Credit Facility to Fuel BRIUMVI Growth and Pipeline Development
去年
TG Therapeutics Reports 91% Revenue Surge Driven by BRIUMVI Multiple Sclerosis Treatment
去年
TG Therapeutics Initiates Phase 3 Trial for Subcutaneous BRIUMVI in Multiple Sclerosis
去年
Roche's High-Dose Ocrevus Fails Phase 3 Trial for Multiple Sclerosis, Boosting TG Therapeutics
去年
TG Therapeutics to Present New BRIUMVI Data in Multiple Sclerosis at ACTRIMS 2025 Forum
去年
TG Therapeutics to Present Six-Year BRIUMVI Data at ECTRIMS 2025, Showcasing Long-Term Multiple Sclerosis Treatment Outcomes
2年前
BRIUMVI Rapid Infusion Shows Promise in Multiple Sclerosis Treatment
第 1 页,共 883 页
上一页
下一页